Capecitabine-Associated Loss of Fingerprints: Report of Capecitabine-Induced Adermatoglyphia in Two Women with Breast Cancer and Review of Acquired Dermatoglyphic Absence in Oncology Patients Treated with Capecitabine.

Cohen PR

Open source

DOI
10.7759/cureus.969
Published
2017 Jan 9
Container
Cureus
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7759/cureus.969,
  title = {Capecitabine-Associated Loss of Fingerprints: Report of Capecitabine-Induced Adermatoglyphia in Two Women with Breast Cancer and Review of Acquired Dermatoglyphic Absence in Oncology Patients Treated with Capecitabine.},
  author = {Cohen PR},
  year = {2017},
  journal = {Cureus},
  doi = {10.7759/cureus.969},
  url = {https://doi.org/10.7759/cureus.969}
}

RIS

TY  - JOUR
TI  - Capecitabine-Associated Loss of Fingerprints: Report of Capecitabine-Induced Adermatoglyphia in Two Women with Breast Cancer and Review of Acquired Dermatoglyphic Absence in Oncology Patients Treated with Capecitabine.
AU  - Cohen PR
PY  - 2017
JO  - Cureus
DO  - 10.7759/cureus.969
UR  - https://doi.org/10.7759/cureus.969
ER  - 

APA

PR, C. (2017). Capecitabine-Associated Loss of Fingerprints: Report of Capecitabine-Induced Adermatoglyphia in Two Women with Breast Cancer and Review of Acquired Dermatoglyphic Absence in Oncology Patients Treated with Capecitabine.. Cureus. https://doi.org/10.7759/cureus.969

Source records